Project details
- Project period
- 1 Jul 2024 - 30 Jun 2027
- Total cost
- €2 926 130,00
- Global Health EDCTP3 funding
- €2 920 255,00
- Call identifier
- HORIZON_HORIZON-JU-GH-EDCTP3-2023-01-04
- Status
- In progress
- Project type
- Research and Innovation Actions (RIA)
- Disease area
- Emerging or re-emerging infectious diseases
- Intervention type
- DiagnosticsSurveillance tools
Rapid detection of Ebola virus infections
The EPoCA project is developing an innovative new point-of-care test for Ebola virus infections that will also give insights into infection severity and automatically alert policymakers of new infections.
The challenge
Ebola virus infections call for rapid action – both clinically, to save patients’ lives, and via public health responses, to halt further transmission. Infections have a high fatality rate and are highly contagious, so diagnoses need to be made as rapidly as possible, for example, using point-of-care tests.
New technologies and materials are enabling rapid diagnostics for Ebola and other infectious diseases. One example is graphene, ultrathin layers of carbon, which can be modified to incorporate detection systems for biomolecules specific to particular pathogens or produced by patients in response to infection. Following the binding of these biomolecules, changes in the graphene detector's properties can be converted into an easily interpreted visual signal.
The project
The EPoCA project is using this approach, known as multiplexed field-effect sensor technology (FET), to develop a rapid, sensitive and specific diagnostic test for Ebola virus infection. Over the past 10 years, graphene FETs have been developed for a range of biosensing uses, providing a strong foundation for the adaptation to Ebola detection.
Using standard blood samples, the technology will detect a mix of viral and host biomolecules, including antibodies indicating infection and host biomarkers that provide a measure of infection severity. These results will be generated rapidly – within 30 minutes – so they can inform immediate patient care, including triage based on infection severity.
In addition, the detector will be integrated into an ‘internet of things’ device, so that diagnostic information can immediately be shared across the web. This will provide policymakers with near-instant epidemiological information to inform public health responses.
The EPoCA project will develop a prototype device, conduct clinical validation studies, and explore manufacturing scale-up. Clinical validation studies will be carried out with project partners at field sites in the Democratic Republic of the Congo (DRC) and Ghana.
Impact
The EPoCA project is leveraging an exciting area of technology development to create a new tool for Ebola control. It will:
- Develop a practical, easy-to-use diagnostic tool for rapid detection of Ebola virus infections at the bedside.
- Enable patients to be rapidly triaged so severe cases receive priority care.
- Deliver near-real-time epidemiological information to public health officials to support rapid response to outbreaks.
- Provide proof-of-concept for a technology that could have multiple applications in infectious disease control and other areas of healthcare in sub-Saharan Africa.
A graphene FET-based diagnostic for the Ebola virus would improve immediate care of Ebola patients, helping to reduce alarmingly high mortality rates, and also support efforts to control the spread of infections through the community.
Consortium map
Coordinator
LIBELIUM LAB SL
- Location
- CEUTI, Spain
- EU contribution
- €448 000,00
- Total cost
- €450 000,00
Beneficiaries
UNIVERSITY OF GHANA
- Location
- LEGON ACCRA, Ghana
- EU contribution
- €207 750,00
- Total cost
- €211 500,00
UNIVERSITA CAMPUS BIO MEDICO DI ROMA
- Location
- Roma, Italy
- EU contribution
- €235 567,50
- Total cost
- €235 567,50
UNIVERSIDAD DE GRANADA
- Location
- GRANADA, Spain
- EU contribution
- €561 875,00
- Total cost
- €561 875,00
INSTITUT NATIONAL DE RECHERCHE BIOMEDICALE DU ZAIRE
- Location
- KINSHASA GOMBE, Democratic Republic of the Congo
- EU contribution
- €205 000,00
- Total cost
- €205 125,00
UNIVERSIDAD COMPLUTENSE DE MADRID
- Location
- MADRID, Spain
- EU contribution
- €538 937,50
- Total cost
- €538 937,50
MEDTRONIC IBERICA SA
- Location
- Madrid, Spain
- EU contribution
- €448 750,00
- Total cost
- €448 750,00
BRIDG OU
- Location
- TALLIN, Estonia
- EU contribution
- €274 375,00
- Total cost
- €274 375,00
Related projects


